PremiumThe FlyAytu BioPharma announces exclusive commercialization agreement for Exxua Aytu BioPharma files to sell 6.74M shares of common stock Aytu BioScience Holds 2025 Annual Meeting PremiumThe FlyEvoke Pharma appoints Greg Pyszczymuka to board of directors Aytu BioScience: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating Aytu BioScience Earnings Call: Growth Amid Challenges PremiumCompany AnnouncementsAytu BioScience Announces Leadership Change and Financial Growth AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings? Aytu BioPharma enters exclusive commercialization agreement with Lupin